Antonio Pérez Martínez-rekin lankidetzan egindako argitalpenak (30)

2023

  1. NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells

    Frontiers in Immunology, Vol. 14

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)

    Medicina Clinica, Vol. 159, Núm. 9, pp. 411-419

2021

  1. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

    European Journal of Haematology, Vol. 106, Núm. 6, pp. 842-850

  2. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH)

    European Journal of Haematology, Vol. 106, Núm. 2, pp. 196-204

2020

  1. COVID-19 infection in children and adolescents with cancer in Madrid

    Pediatric Blood and Cancer

  2. Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)

    American Journal of Hematology, Vol. 95, Núm. 1, pp. 28-37

2017

  1. Early clinical trials in paediatric oncology in Spain: a nationwide perspective

    Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163

  2. Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacional

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 87, Núm. 3, pp. 155-163

2014

  1. Cunninghamella bertholletiae infection in children: Review and report of 2 cases with disseminated infection

    Journal of Pediatric Hematology/Oncology, Vol. 36, Núm. 2

2013

  1. Defining "poor mobilizer" in pediatric patients who need an autologous peripheral blood progenitor cell transplantation

    Cytotherapy, Vol. 15, Núm. 1, pp. 132-137

  2. Management of children with brain tumors in paraguay

    Neuro-Oncology, Vol. 15, Núm. 2, pp. 235-241

2010

  1. Exercise during hematopoietic stem cell transplant hospitalization in children

    Medicine and Science in Sports and Exercise, Vol. 42, Núm. 6, pp. 1045-1053

  2. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: A long-term follow-up single-center study

    Pediatric Hematology and Oncology, Vol. 27, Núm. 4, pp. 272-282

2009

  1. Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors

    Journal of Neuro-Oncology, Vol. 95, Núm. 1, pp. 65-69

  2. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors

    Pediatric Blood and Cancer, Vol. 53, Núm. 1, pp. 120-124

  3. Peripheral blood progenitor cell collection adverse events for childhood allogeneic donors: Variables related to the collection and safety profile

    British Journal of Haematology, Vol. 144, Núm. 6, pp. 909-916

2008

  1. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients

    British Journal of Haematology, Vol. 140, Núm. 3, pp. 340-343

2007

  1. End of life in a cross-cultural context - Immigrant children with end-stage cancer

    Medicina Paliativa, Vol. 14, Núm. 4, pp. 236-242

  2. Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow

    Journal of Pediatric Hematology/Oncology, Vol. 29, Núm. 6, pp. 388-392